Article
Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis.
Journal of clinical pathology - 1 Nov 2007
Rowe Leslie R, Bentz Brandon G, Bentz Joel S
Abstract excerpt
BACKGROUND: A single hotspot mutation at nucleotide 1799 of the BRAF gene has been identified as the most common genetic event in papillary thyroid carcinoma (PTC), with a prevalence of 29-83%. AIMS: To use a PCR assay to molecularly characterise the BRAF activating point mutation in a series of PTC and benign thyroid cases and correlate the mutation results with histological findings. METHODS: Formalin-fixed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
